Old Web
English
Sign In
Acemap
>
authorDetail
>
Katie McFadyen
Katie McFadyen
Janssen Pharmaceutica
Medicine
Pharmacokinetics
Bronchiolitis
Respiratory system
Virology
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics, Safety and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized with RSV Infection: A Randomized Phase 1b Study.
2020
Clinical Infectious Diseases
Federico Martinón-Torres
Sarah Rusch
Dymphy Huntjens
Bart Remmerie
Johan Vingerhoets
Katie McFadyen
Fernando Ferrero
Eugenio Baraldi
Pablo Rojo
Cristina Epalza
Marita Stevens
Show All
Source
Cite
Save
Citations (9)
1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
2018
Open Forum Infectious Diseases
Federico Martinón-Torres
Sarah Rusch
Dymphy Huntjens
Bart Remmerie
Johan Vingerhoets
Katie McFadyen
Fernando Ferrero
Eugenio Baraldi
Pablo Rojo Conejo
Cristina Epalza
Marita Stevens
Show All
Source
Cite
Save
Citations (4)
1